文献速递消化道肿瘤放疗放疗物理与技术

食管癌四维容积旋转调强放疗中膈肌呼吸运动对剂量学影响的新型模拟方法

Novel simulation for dosimetry impact of diaphragm respiratory motion in four-dimensional volumetric modulated arc therapy for esophageal cancer.
PubMed 文献 · Radiother Oncol · 2023-08-09

研究纳入10例浅表性食管癌患者,基于吸气末CT构建虚拟4DCT(v4DCT)并累积v4DRT剂量,与真实4DCT(r4DCT)比较验证;膈肌运动≤15 mm时CTV的ΔDx差异在1%以内,平均ΔD100%为0.3%–1.7%、ΔDmean为0.1%–0.4%,所有CTV指标变化在3%以内。

要点

  • 膈肌运动≤15 mm时,r4DRT与v4DRT的CTV ΔDx差异在1%以内。
  • 膈肌运动5–15 mm时,CTV平均ΔD100%为0.3%–1.7%,ΔDmean为0.1%–0.4%。
  • 所有CTV指标变化在3%以内,脊髓PRV的ΔD1cc和ΔD2cc在1%以内。

核心结论

  • 作者提出一种评估CTV稳健性的新方法,在膈肌呼吸运动≤15 mm时与传统r4DCT方法可比,对食管癌FB-VMAT的CTV剂量分布影响在3%以内。

研究设计与样本

  • 研究评估10例浅表性食管癌患者的真实4DCT(r4DCT)扫描。
  • 虚拟4DCT图像由吸气末CT图像(参考CT)派生,v4DRT剂量为所有时相累积剂量。
  • 将r4DCT扫描所得的膈肌位移幅度应用于r4DRT,比较v4DRT与r4DRT的CTV剂量以验证v4DRT。

主要发现

  • 膈肌运动≤15 mm的病例中,r4DRT与v4DRT的CTV ΔDx差异在1%以内。
  • 膈肌运动5至15 mm时,CTV平均ΔD100%为0.3%至1.7%,平均ΔDmean为0.1%至0.4%。
  • 所有CTV指标变化在3%以内,脊髓PRV的ΔD1cc和ΔD2cc在1%以内。

关键数值与推荐

  • ΔDx为v4DRT与参考CT图像计算剂量之间的百分比剂量差异。
  • 评估指标包括CTV的ΔD100%、ΔDmean及所有CTV指标变化,以及脊髓PRV的ΔD1cc和ΔD2cc。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The diaphragm respiratory motion (RM) could impact the target dose robustness in the lower esophageal cancer (EC). We aimed to develop a framework evaluating the impact of different RM patterns quantitatively in one patient, by creating virtual four-dimensional computed-tomography (v4DCT) images, which could lead to tailored treatment for the breathing pattern. We validated virtual 4D radiotherapy (v4DRT) along with exploring the acceptability of free-breathing volumetric modulated arc therapy (FB-VMAT). METHODS AND MATERIALS: We assessed 10 patients with superficial EC through their real 4DCT (r4DCT) scans. v4DCT images were derived from the end-inhalation computed tomography (CT) image (reference CT) and the v4DRT dose was accumulated dose over all phases. r4DRT diaphragm shifts were applied with magnitudes derived from r4DCT scans; clinical target volume (CTV) dose of v4DRT was compared with that of r4DRT to validate v4DRT. CTV dosage modifications and planning organ at risk volume (PRV) margins of the spinal cord were examined with the diaphragm movement. The percentage dose differences (ΔDx) were determined between the v4DRT and the dose calculated on the reference CT image. RESULTS: The CTV ΔDx between the r4DRT and v4DRT were within 1% in cases with RM ≦ 15 mm. The average ΔD100% and ΔDmean of the CTV ranging from 5 to 15 mm of diaphragm motion was 0.3% to 1.7% and 0.1% to 0.4%, respectively. All CTV index changes were within 3% and ΔD1cc and ΔD2cc of Cord PRV were within 1%. CONCLUSION: We postulate a novel method for evaluating the CTV robustness, comparable to the conventional r4DCT method under the diaphragm RM ≦ 15 mm permitting an impact of within 3% in FB-VMAT for EC on the CTV dose distribution.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Katsuta T, Murakami Y, Kawahara D, et al. Novel simulation for dosimetry impact of diaphragm respiratory motion in four-dimensional volumetric modulated arc therapy for esophageal cancer. Radiother Oncol. 2023. PMID: 37562552. doi:10.1016/j.radonc.2023.109849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。